Copyright Reports & Markets. All rights reserved.

Global 2019-nCoV Test Kit Market Research Report 2021

Request for Sample of this report
Buy now

1 2019-nCoV Test Kit Market Overview

  • 1.1 Product Overview and Scope of 2019-nCoV Test Kit
  • 1.2 2019-nCoV Test Kit Segment by Type
    • 1.2.1 Global 2019-nCoV Test Kit Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Nucleic Acid Test Kit
    • 1.2.3 Antibody Test Kit
  • 1.3 2019-nCoV Test Kit Segment by Application
    • 1.3.1 2019-nCoV Test Kit Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Scientific Research
    • 1.3.4 Diagnostic Center
  • 1.4 Global 2019-nCoV Test Kit Market Size Estimates and Forecasts
    • 1.4.1 Global 2019-nCoV Test Kit Revenue 2016-2027
    • 1.4.2 Global 2019-nCoV Test Kit Sales 2016-2027
    • 1.4.3 2019-nCoV Test Kit Market Size by Region: 2016 Versus 2021 Versus 2027

2 2019-nCoV Test Kit Market Competition by Manufacturers

  • 2.1 Global 2019-nCoV Test Kit Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global 2019-nCoV Test Kit Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global 2019-nCoV Test Kit Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers 2019-nCoV Test Kit Manufacturing Sites, Area Served, Product Type
  • 2.5 2019-nCoV Test Kit Market Competitive Situation and Trends
    • 2.5.1 2019-nCoV Test Kit Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest 2019-nCoV Test Kit Players Market Share by Revenue
    • 2.5.3 Global 2019-nCoV Test Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 2019-nCoV Test Kit Retrospective Market Scenario by Region

  • 3.1 Global 2019-nCoV Test Kit Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global 2019-nCoV Test Kit Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America 2019-nCoV Test Kit Market Facts & Figures by Country
    • 3.3.1 North America 2019-nCoV Test Kit Sales by Country
    • 3.3.2 North America 2019-nCoV Test Kit Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe 2019-nCoV Test Kit Market Facts & Figures by Country
    • 3.4.1 Europe 2019-nCoV Test Kit Sales by Country
    • 3.4.2 Europe 2019-nCoV Test Kit Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific 2019-nCoV Test Kit Market Facts & Figures by Region
    • 3.5.1 Asia Pacific 2019-nCoV Test Kit Sales by Region
    • 3.5.2 Asia Pacific 2019-nCoV Test Kit Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America 2019-nCoV Test Kit Market Facts & Figures by Country
    • 3.6.1 Latin America 2019-nCoV Test Kit Sales by Country
    • 3.6.2 Latin America 2019-nCoV Test Kit Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa 2019-nCoV Test Kit Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa 2019-nCoV Test Kit Sales by Country
    • 3.7.2 Middle East and Africa 2019-nCoV Test Kit Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global 2019-nCoV Test Kit Historic Market Analysis by Type

  • 4.1 Global 2019-nCoV Test Kit Sales Market Share by Type (2016-2021)
  • 4.2 Global 2019-nCoV Test Kit Revenue Market Share by Type (2016-2021)
  • 4.3 Global 2019-nCoV Test Kit Price by Type (2016-2021)

5 Global 2019-nCoV Test Kit Historic Market Analysis by Application

  • 5.1 Global 2019-nCoV Test Kit Sales Market Share by Application (2016-2021)
  • 5.2 Global 2019-nCoV Test Kit Revenue Market Share by Application (2016-2021)
  • 5.3 Global 2019-nCoV Test Kit Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Thermo Fisher Scientific
    • 6.1.1 Thermo Fisher Scientific Corporation Information
    • 6.1.2 Thermo Fisher Scientific Description and Business Overview
    • 6.1.3 Thermo Fisher Scientific 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Thermo Fisher Scientific Product Portfolio
    • 6.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 6.2 LabCorp
    • 6.2.1 LabCorp Corporation Information
    • 6.2.2 LabCorp Description and Business Overview
    • 6.2.3 LabCorp 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 LabCorp Product Portfolio
    • 6.2.5 LabCorp Recent Developments/Updates
  • 6.3 Cepheid
    • 6.3.1 Cepheid Corporation Information
    • 6.3.2 Cepheid Description and Business Overview
    • 6.3.3 Cepheid 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Cepheid Product Portfolio
    • 6.3.5 Cepheid Recent Developments/Updates
  • 6.4 Hologic
    • 6.4.1 Hologic Corporation Information
    • 6.4.2 Hologic Description and Business Overview
    • 6.4.3 Hologic 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hologic Product Portfolio
    • 6.4.5 Hologic Recent Developments/Updates
  • 6.5 Danaher
    • 6.5.1 Danaher Corporation Information
    • 6.5.2 Danaher Description and Business Overview
    • 6.5.3 Danaher 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Danaher Product Portfolio
    • 6.5.5 Danaher Recent Developments/Updates
  • 6.6 Roche Diagnostics
    • 6.6.1 Roche Diagnostics Corporation Information
    • 6.6.2 Roche Diagnostics Description and Business Overview
    • 6.6.3 Roche Diagnostics 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Roche Diagnostics Product Portfolio
    • 6.6.5 Roche Diagnostics Recent Developments/Updates
  • 6.7 BioMérieux
    • 6.6.1 BioMérieux Corporation Information
    • 6.6.2 BioMérieux Description and Business Overview
    • 6.6.3 BioMérieux 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BioMérieux Product Portfolio
    • 6.7.5 BioMérieux Recent Developments/Updates
  • 6.8 Integrated DNA Technologies
    • 6.8.1 Integrated DNA Technologies Corporation Information
    • 6.8.2 Integrated DNA Technologies Description and Business Overview
    • 6.8.3 Integrated DNA Technologies 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Integrated DNA Technologies Product Portfolio
    • 6.8.5 Integrated DNA Technologies Recent Developments/Updates
  • 6.9 Abbott Laboratories
    • 6.9.1 Abbott Laboratories Corporation Information
    • 6.9.2 Abbott Laboratories Description and Business Overview
    • 6.9.3 Abbott Laboratories 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Abbott Laboratories Product Portfolio
    • 6.9.5 Abbott Laboratories Recent Developments/Updates
  • 6.10 Beijing Genomics Institute
    • 6.10.1 Beijing Genomics Institute Corporation Information
    • 6.10.2 Beijing Genomics Institute Description and Business Overview
    • 6.10.3 Beijing Genomics Institute 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Beijing Genomics Institute Product Portfolio
    • 6.10.5 Beijing Genomics Institute Recent Developments/Updates
  • 6.11 Shanghai Huirui Biotechnology
    • 6.11.1 Shanghai Huirui Biotechnology Corporation Information
    • 6.11.2 Shanghai Huirui Biotechnology 2019-nCoV Test Kit Description and Business Overview
    • 6.11.3 Shanghai Huirui Biotechnology 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Shanghai Huirui Biotechnology Product Portfolio
    • 6.11.5 Shanghai Huirui Biotechnology Recent Developments/Updates
  • 6.12 Geneodx
    • 6.12.1 Geneodx Corporation Information
    • 6.12.2 Geneodx 2019-nCoV Test Kit Description and Business Overview
    • 6.12.3 Geneodx 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Geneodx Product Portfolio
    • 6.12.5 Geneodx Recent Developments/Updates
  • 6.13 Shanghai BioGerm Medical Biotechnology
    • 6.13.1 Shanghai BioGerm Medical Biotechnology Corporation Information
    • 6.13.2 Shanghai BioGerm Medical Biotechnology 2019-nCoV Test Kit Description and Business Overview
    • 6.13.3 Shanghai BioGerm Medical Biotechnology 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Shanghai BioGerm Medical Biotechnology Product Portfolio
    • 6.13.5 Shanghai BioGerm Medical Biotechnology Recent Developments/Updates
  • 6.14 Da An Gene
    • 6.14.1 Da An Gene Corporation Information
    • 6.14.2 Da An Gene 2019-nCoV Test Kit Description and Business Overview
    • 6.14.3 Da An Gene 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Da An Gene Product Portfolio
    • 6.14.5 Da An Gene Recent Developments/Updates
  • 6.15 Wondfo
    • 6.15.1 Wondfo Corporation Information
    • 6.15.2 Wondfo 2019-nCoV Test Kit Description and Business Overview
    • 6.15.3 Wondfo 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Wondfo Product Portfolio
    • 6.15.5 Wondfo Recent Developments/Updates
  • 6.16 INNOVITA
    • 6.16.1 INNOVITA Corporation Information
    • 6.16.2 INNOVITA 2019-nCoV Test Kit Description and Business Overview
    • 6.16.3 INNOVITA 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 INNOVITA Product Portfolio
    • 6.16.5 INNOVITA Recent Developments/Updates
  • 6.17 Kogenebiotech
    • 6.17.1 Kogenebiotech Corporation Information
    • 6.17.2 Kogenebiotech 2019-nCoV Test Kit Description and Business Overview
    • 6.17.3 Kogenebiotech 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Kogenebiotech Product Portfolio
    • 6.17.5 Kogenebiotech Recent Developments/Updates
  • 6.18 Mylab Discovery
    • 6.18.1 Mylab Discovery Corporation Information
    • 6.18.2 Mylab Discovery 2019-nCoV Test Kit Description and Business Overview
    • 6.18.3 Mylab Discovery 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Mylab Discovery Product Portfolio
    • 6.18.5 Mylab Discovery Recent Developments/Updates
  • 6.19 Altona Diagnostics
    • 6.19.1 Altona Diagnostics Corporation Information
    • 6.19.2 Altona Diagnostics 2019-nCoV Test Kit Description and Business Overview
    • 6.19.3 Altona Diagnostics 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Altona Diagnostics Product Portfolio
    • 6.19.5 Altona Diagnostics Recent Developments/Updates
  • 6.20 Seegene
    • 6.20.1 Seegene Corporation Information
    • 6.20.2 Seegene 2019-nCoV Test Kit Description and Business Overview
    • 6.20.3 Seegene 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Seegene Product Portfolio
    • 6.20.5 Seegene Recent Developments/Updates
  • 6.21 SD Biosensor
    • 6.21.1 SD Biosensor Corporation Information
    • 6.21.2 SD Biosensor 2019-nCoV Test Kit Description and Business Overview
    • 6.21.3 SD Biosensor 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 SD Biosensor Product Portfolio
    • 6.21.5 SD Biosensor Recent Developments/Updates
  • 6.22 Biomaxima
    • 6.22.1 Biomaxima Corporation Information
    • 6.22.2 Biomaxima 2019-nCoV Test Kit Description and Business Overview
    • 6.22.3 Biomaxima 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Biomaxima Product Portfolio
    • 6.22.5 Biomaxima Recent Developments/Updates
  • 6.23 Quidel
    • 6.23.1 Quidel Corporation Information
    • 6.23.2 Quidel 2019-nCoV Test Kit Description and Business Overview
    • 6.23.3 Quidel 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 Quidel Product Portfolio
    • 6.23.5 Quidel Recent Developments/Updates
  • 6.24 Qiagen
    • 6.24.1 Qiagen Corporation Information
    • 6.24.2 Qiagen 2019-nCoV Test Kit Description and Business Overview
    • 6.24.3 Qiagen 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 Qiagen Product Portfolio
    • 6.24.5 Qiagen Recent Developments/Updates
  • 6.25 GenMark Diagnostics
    • 6.25.1 GenMark Diagnostics Corporation Information
    • 6.25.2 GenMark Diagnostics 2019-nCoV Test Kit Description and Business Overview
    • 6.25.3 GenMark Diagnostics 2019-nCoV Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 GenMark Diagnostics Product Portfolio
    • 6.25.5 GenMark Diagnostics Recent Developments/Updates

7 2019-nCoV Test Kit Manufacturing Cost Analysis

  • 7.1 2019-nCoV Test Kit Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of 2019-nCoV Test Kit
  • 7.4 2019-nCoV Test Kit Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 2019-nCoV Test Kit Distributors List
  • 8.3 2019-nCoV Test Kit Customers

9 2019-nCoV Test Kit Market Dynamics

  • 9.1 2019-nCoV Test Kit Industry Trends
  • 9.2 2019-nCoV Test Kit Growth Drivers
  • 9.3 2019-nCoV Test Kit Market Challenges
  • 9.4 2019-nCoV Test Kit Market Restraints

10 Global Market Forecast

  • 10.1 2019-nCoV Test Kit Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of 2019-nCoV Test Kit by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of 2019-nCoV Test Kit by Type (2022-2027)
  • 10.2 2019-nCoV Test Kit Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of 2019-nCoV Test Kit by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of 2019-nCoV Test Kit by Application (2022-2027)
  • 10.3 2019-nCoV Test Kit Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of 2019-nCoV Test Kit by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of 2019-nCoV Test Kit by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Nucleic Acid Test Kit
    Antibody Test Kit

    Segment by Application
    Hospital
    Scientific Research
    Diagnostic Center

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Thermo Fisher Scientific
    LabCorp
    Cepheid
    Hologic
    Danaher
    Roche Diagnostics
    BioMérieux
    Integrated DNA Technologies
    Abbott Laboratories
    Beijing Genomics Institute
    Shanghai Huirui Biotechnology
    Geneodx
    Shanghai BioGerm Medical Biotechnology
    Da An Gene
    Wondfo
    INNOVITA
    Kogenebiotech
    Mylab Discovery
    Altona Diagnostics
    Seegene
    SD Biosensor
    Biomaxima
    Quidel
    Qiagen
    GenMark Diagnostics

    Buy now